Prelude Therapeutics PRLD
NASDAQ PRLD
$3.67 -0.12 (-3.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Cash from Investing Activities (2019 - 2026)

Updated

Prelude Therapeutics' Cash from Investing Activities was -$65.5 million in Q2 2026, compared with $11.52 million a year earlier.

Analysis

Prelude Therapeutics (PRLD) Cash from Investing Activities (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Prelude Therapeutics' Cash from Investing Activities was -$77.25 million through Jun 30, 2026; for FY2025, it came in at $53.46 million, down 40.7% from FY2024.

  • In earlier years, Cash from Investing Activities was $90.19 million in FY2024, -$34.65 million in FY2023, $81.69 million in FY2022 and -$263.8 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Cash from Investing Activities since Q2 2023.
  • Compared with a year earlier, Cash from Investing Activities was higher in three of the last six quarters, with growth averaging 64.6%.
  • The best year-over-year quarter for Cash from Investing Activities over five years was Q4 2023 (growth of 470.9%); the worst was Q1 2026 (a decline of 86.3%).
  • Per Business Quant data, PRLD's Cash from Investing Activities in the three quarters before Q2 2026 was $8.5 million (Q1 2026), -$60.34 million (Q4 2025) and $40.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Prelude Therapeutics 292.88 Mn -304.42 Mn - -65.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.50 Mn
Mar 31, 2026 8.50 Mn
Dec 31, 2025 -60.34 Mn
Sep 30, 2025 40.09 Mn
Jun 30, 2025 11.52 Mn
Mar 31, 2025 62.19 Mn
Dec 31, 2024 22.12 Mn
Sep 30, 2024 10.73 Mn
Jun 30, 2024 26.12 Mn
Mar 31, 2024 31.22 Mn
Dec 31, 2023 7.74 Mn
Sep 30, 2023 15.05 Mn
Jun 30, 2023 -75.43 Mn
Mar 31, 2023 18.00 Mn
Dec 31, 2022 1.36 Mn
Sep 30, 2022 21.61 Mn
Jun 30, 2022 58.58 Mn
Mar 31, 2022 153,000.00
Dec 31, 2021 -1.80 Mn
Sep 30, 2021 -260.63 Mn
API Access

Prelude Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PRLD&period=max&api_key=YOUR_API_KEY